San Diego, CA, United States of America

Agnes Vidal

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Irm LLC. Active years: 2011-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Agnes Vidal. Retrieved from https://idiyas.com/inventor/agnes-vidal-6ggukzr2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Agnes Vidal

Introduction

Agnes Vidal is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate channel activating proteases. With a total of two patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Agnes Vidal's latest patents focus on "Compounds and compositions as channel activating protease inhibitors." These inventions provide compounds and pharmaceutical compositions that are useful for modulating channel activating proteases. The methods described in her patents aim to treat, ameliorate, or prevent conditions associated with various channel activating proteases, including prostasin, PRSS22, TMPRSS11, TMPRSS2, TMPRSS3, TMPRSS4, matriptase, CAP2, CAP3, trypsin, cathepsin A, and neutrophil elastase.

Career Highlights

Agnes Vidal is currently associated with Irm LLC, where she continues to innovate and develop her research. Her work has garnered attention in the scientific community, contributing to advancements in medical treatments.

Collaborations

Some of her notable coworkers include David C. Tully and Hank Michael James Petrassi. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Agnes Vidal's contributions to the field of pharmaceutical sciences through her innovative patents demonstrate her commitment to advancing medical treatments. Her work continues to inspire future research and development in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…